Opinions about scientific advances blur party-political lines
By Matthew Nisbet and Ezra Markowitz,
The Conversation
| 02. 19. 2014
Reading about the rapid pace of advances in biomedicine, you may have wondered why more politically liberal countries like Germany and Canada have stronger restrictions on embryonic stem cell research than the politically conservative US.
History and happenstance play a role, but these differences also reflect public concerns that do not conform to traditional left or right political ideologies.
As debates over stem cell research continue and as conflicts over other biomedical advances emerge, a recurring set of questions is likely to be seen. Do scientific breakthroughs promote or undermine social progress? Is research being pursued too cautiously or too quickly? Do scientists respect or cross moral boundaries?
In a study, just published in PLOS ONE, we analysed a series of surveys collected between 2002 and 2010 to better understand what the US public thinks about stem cell research and how they formed these opinions. We were able to distinguish between the different factors influencing their beliefs. At play were factors such as traditional loyalties to political parties and more fundamental beliefs about science and society.
Our results indicate...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...